Open Interest and Volume Dynamics
On 4 May 2026, Lupin’s open interest in derivatives rose sharply by 3,100 contracts, marking a 12.82% increase from the previous figure of 24,187 to 27,287. This substantial uptick in OI was accompanied by a daily volume of 18,481 contracts, reflecting active trading interest. The futures segment alone accounted for a value of approximately ₹25,508.79 lakhs, while the options segment exhibited an enormous notional value of ₹16,501.85 crores, culminating in a total derivatives value of ₹28,855.80 lakhs.
This surge in open interest, combined with elevated volumes, typically indicates fresh positions being established rather than existing ones being squared off. Such a pattern often points to a directional conviction among market participants, suggesting that traders are positioning themselves for a potential price movement in the underlying stock.
Price Performance and Technical Indicators
Lupin’s underlying stock price closed at ₹2,344, just 1.94% shy of its 52-week high of ₹2,381, demonstrating strong price momentum. The stock outperformed its sector by 0.59% and the broader Sensex by 1.07% on the day, with a 1-day return of 1.45% compared to the sector’s 0.71% and Sensex’s 0.38%. Intraday, Lupin touched a high of ₹2,361.90, gaining 2.46% from the previous close.
Technically, Lupin is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a sustained uptrend. This alignment of moving averages often attracts momentum traders and institutional investors, reinforcing the bullish outlook.
Investor Participation and Liquidity
Investor interest has been on the rise, as evidenced by the delivery volume of 7.11 lakh shares on 30 April, which surged 21.73% above the five-day average delivery volume. This increase in delivery volume indicates genuine buying interest rather than speculative intraday trading. Furthermore, the stock’s liquidity remains robust, with the capacity to handle trade sizes of up to ₹5.02 crores based on 2% of the five-day average traded value, ensuring smooth execution for large orders.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
Market Positioning and Directional Bets
The sharp increase in open interest alongside rising volumes suggests that market participants are taking fresh positions in Lupin’s derivatives, likely anticipating further upside in the stock price. The futures value of ₹25,508.79 lakhs and the massive options notional value indicate significant hedging and speculative activity.
Given Lupin’s recent upgrade in its Mojo Grade from Buy to Strong Buy on 27 April 2026, with a high Mojo Score of 81.0, investors appear confident in the company’s growth prospects. The mid-cap pharmaceutical firm, with a market capitalisation of ₹1,06,642 crores, is benefiting from favourable sector dynamics and robust earnings visibility.
Options data, although not detailed here, likely reflects a skew towards call options, which would be consistent with bullish sentiment. The proximity to the 52-week high and the stock’s outperformance relative to its sector and benchmark indices further support the view that investors are positioning for continued gains.
Sector and Industry Context
Lupin operates within the Pharmaceuticals & Biotechnology sector, which has shown resilience amid global uncertainties. The company’s strong fundamentals, including steady revenue growth and expanding margins, have contributed to its upgraded rating. The sector’s overall performance has been positive, but Lupin’s outperformance highlights its relative strength.
Investors should note that while the surge in open interest and volume is encouraging, it also warrants caution as elevated derivatives activity can sometimes precede increased volatility. Monitoring the stock’s price action in conjunction with open interest trends will be crucial for gauging the sustainability of the current momentum.
Get the full story on Lupin Ltd.! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this Pharmaceuticals & Biotechnology mid-cap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
Outlook and Investor Takeaways
With Lupin’s derivatives open interest rising by nearly 13% and the stock trading near its 52-week high, the market is signalling a positive outlook. The upgrade to a Strong Buy rating by MarketsMOJO, supported by a high Mojo Score of 81.0, reinforces confidence in the company’s growth trajectory.
Investors should consider Lupin’s strong technical positioning, rising investor participation, and sector tailwinds when evaluating their portfolios. The stock’s liquidity and ability to absorb sizeable trades make it an attractive option for both institutional and retail investors seeking exposure to the pharmaceutical space.
However, as with any mid-cap stock, volatility remains a factor, and prudent risk management is advised. Monitoring open interest trends alongside price movements will provide valuable insights into evolving market sentiment and potential directional shifts.
Summary
Lupin Ltd.’s recent surge in open interest and volume in the derivatives market reflects growing bullish sentiment and fresh positioning by traders. Supported by strong fundamentals, technical strength, and an upgraded Mojo Grade, the stock is poised for potential further gains. Investors should remain attentive to market signals and sector developments to capitalise on this momentum effectively.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
